1. Home
  2. STRS vs ADAG Comparison

STRS vs ADAG Comparison

Compare STRS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$28.31

Market Cap

230.9M

Sector

Real Estate

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.78

Market Cap

254.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
ADAG
Founded
1992
2011
Country
United States
China
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.9M
254.4M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
STRS
ADAG
Price
$28.31
$3.78
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.25
AVG Volume (30 Days)
30.2K
132.2K
Earning Date
05-14-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
512.50
N/A
EPS
0.82
N/A
Revenue
$29,914,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.35
$1.44
52 Week High
$32.93
$4.75

Technical Indicators

Market Signals
Indicator
STRS
ADAG
Relative Strength Index (RSI) 36.57 52.63
Support Level $28.22 $3.31
Resistance Level $31.37 $3.99
Average True Range (ATR) 0.82 0.33
MACD -0.07 0.04
Stochastic Oscillator 15.49 57.26

Price Performance

Historical Comparison
STRS
ADAG

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: